¼¼°èÀÇ È¾°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ±â¼úº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº°-»ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, Á¡À¯À², ¿¹Ãø
Diaphragm Pacing Therapy System Market, By Product Type, By Application, By Technology, By End-User, By Country, and By Region-Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»óǰÄÚµå : 1629182
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 379 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,702,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,728,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,174,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â 2024³â 55¾ï 6,723¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 7.5%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå ¿ªÇÐ

±â¼ú Çõ½ÅÀ¸·Î ÀåÄ¡ ºñ¿ëÀ» Àý°¨Çϰí ȯÀÚÀÇ °¡¿ë¼ºÀ» Çâ»ó

Ⱦ°Ý¸· ÆäÀÌ½Ì ½Ã½ºÅÛÀÇ ±â¼ú Çõ½ÅÀº ÀåÄ¡ ºñ¿ëÀ» ÁÙÀÌ°í º¸´Ù ±¤¹üÀ§ÇÑ È¯ÀÚÃþ¿¡ ´ëÇÑ ½Ã½ºÅÛ º¸±Þ¿¡ ±â¿©Çϱ⠶§¹®¿¡ ½ÃÀåÀÇ Áß¿äÇÑ ÃËÁø¿äÀÎÀÌ µÇ¾ú½À´Ï´Ù. ¼ÒÇüÈ­, ¹èÅ͸® ¼ö¸í ¹× ¹«¼± ¿¬°áÀÇ ¹ßÀüÀ¸·Î DPT ½Ã½ºÅÛÀº º¸´Ù Àú·ÅÇÏ°í »ç¿ëÇϱ⠽±½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¶ÇÇÑ ÀåºñÀÇ Àü¹ÝÀûÀÎ È¿À²¼º°ú Æí¾ÈÇÔÀ» Çâ»ó½ÃŰ°í ±âÁ¸ÀÇ ±â°èÀû Àΰø È£ÈíÀ» ´ëüÇÏ´Â Çö½ÇÀûÀÎ ¼±ÅÃÀÌ µÇ¾ú½À´Ï´Ù. ±× °á°ú, ÀÇ·á Á¦°ø¾÷ü´Â ƯÈ÷ ¸¸¼º È£Èí±â Áúȯ ȯÀÚ¿¡°Ô Ⱦ°Ý¸· ÆäÀÌ½Ì ±â¼úÀ» äÅÃÇϱ⠽¬¿öÁ³½À´Ï´Ù.

°Ô´Ù°¡, º¸´Ù ºñ¿ë È¿À²ÀûÀÎ Á¦Á¶ °øÁ¤ÀÇ °³¹ß·Î, ƯÈ÷ ÀÇ·á°¡ Àß µÇÁö ¾Ê´Â Áö¿ªÀ̳ª Àú¼ÒµæÀÇ Áö¿ª¿¡¼­µµ, º¸´Ù Æø³ÐÀº ½ÃÀå¿¡ ´ëÇÑ º¸±ÞÀÌ °¡´ÉÇÏ°Ô µË´Ï´Ù. ¹Ì±¹¸³À§»ý¿¬±¸¼Ò(NIH)ÀÇ º¸°í¼­¿¡ µû¸£¸é, Ⱦ°Ý¸· ÆäÀ̽ÌÀ» Æ÷ÇÔÇÑ ÀÇ·á±â±âÀÇ ±â¼ú Áøº¸·Î Áö³­ 10³â°£ ±â±âÀÇ ºñ¿ëÀÌ 15-20% ÀúÇÏµÇ¾î º¸´Ù ¸¹Àº ȯÀÚÃþÀÌ ÀÌ¿ëÇϱ⠽¬¿öÁö°í ÀÖ½À´Ï´Ù. À̰ÍÀº DPT ½Ã½ºÅÛ ½ÃÀåÀ» È®´ëÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå : ÁÖ¿ä °í·Á »çÇ×

¿ì¸®ÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2025-2032³â)¿¡ ¾à 7.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î À̽ÄÇü Ⱦ°Ý¸· ÆäÀÌ½Ì ½Ã½ºÅÛ(IDPS)Àº 2024³â ÃÖ´ë ½ÃÀå Á¡À¯À²À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿ëµµº°·Î ô¼ö ¼Õ»ó(SCI)Àº 2024³â ÁÖ¿ä ¿ëµµ¿´½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â ÁÖ¿ä ¼öÀÍ¿øÀÌ µÇ¾ú½À´Ï´Ù.

Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå : ¼¼ºÐÈ­ ºÐ¼®

¼¼°èÀÇ È¾°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀåÀº Á¦Ç° À¯Çüº°, ¿ëµµº°, ±â¼úº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°·Î ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº Á¦Ç° À¯Çüº°·Î 2°¡Áö·Î ºÐ·ùµË´Ï´Ù. : ü¿ÜÇü Ⱦ°Ý¸· ÆäÀÌ½Ì ½Ã½ºÅÛ°ú À̽ÄÇü Ⱦ°Ý¸· ÆäÀÌ½Ì ½Ã½ºÅÛ. Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå¿¡¼­ À̽ÄÇü Ⱦ°Ý¸· ÆäÀÌ½Ì ½Ã½ºÅÛ(IDPS)Àº °¡Àå Áß¿äÇÑ ºÎ¹®À¸·Î Áö¹èÀûÀÔ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº È£Èí ºÎÀü ȯÀÚ, ƯÈ÷ ô¼ö ¼Õ»óÀ̳ª ½Å°æ±Ù Àå¾Ö°¡ Àִ ȯÀÚ¿¡°Ô Àå±âÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â Áö¿øÀ» Á¦°øÇÕ´Ï´Ù. À̽ÄÇü ½Ã½ºÅÛÀº ü¿ÜÇü ½Ã½ºÅÛº¸´Ù ´«¿¡ ¶çÁö ¾Ê°í È¿À²ÀûÀÌ¸ç Æí¸®Çϱ⠶§¹®¿¡ ¸¸¼º »ç¿ë¿¡ ÀûÇÕÇÕ´Ï´Ù. Áö¼ÓÀûÀ̰í ÀÚÀ²ÀûÀΠȾ°Ý¸· ÀÚ±ØÀ» Á¦°øÇÒ ¼ö ÀÖ¾î ȯÀÚÀÇ QOLÀÌ Çâ»óµÇ¾î º¸±Þ°ú ½ÃÀåÀÇ ÁÖ¸ñÀ» ¸ðÀ¸´Â ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ü¿ÜÇü Ⱦ°Ý¸· ÆäÀÌ½Ì ½Ã½ºÅÛÀº Áß¿äÇÏÁö¸¸, ÀϹÝÀûÀ¸·Î ´Ü±â°£ ¶Ç´Â ±×´ÙÁö ½É°¢ÇÏÁö ¾ÊÀº »óÅ¿¡¼­ »ç¿ëµË´Ï´Ù.

½ÃÀåÀº ¿ëµµº°·Î ³× °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ô¼ö ¼Õ»ó, ±ÙÀ§Ã༺ Ãø»è °æÈ­Áõ(ALS), ¼±Ãµ¼º ÁßÃß¼º Àúȯ±â ÁõÈıº(CCHS), ±âŸ µî. Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ô¼ö ¼Õ»ó(SCI)Àº °¡Àå µÎµå·¯Áø ¿ëµµ ºÐ¾ßÀÔ´Ï´Ù. SCI ȯÀÚ, ƯÈ÷ °íÂ÷ ¼Õ»ó ȯÀÚ´Â Á¾Á¾ Ⱦ°Ý¸· ¸¶ºñ·Î ÀÎÇÑ È£Èí ºÎÀüÀ¸·Î °íÅë¹Þ½À´Ï´Ù. Ⱦ°Ý¸· ÆäÀÌ½Ì ½Ã½ºÅÛÀº À̵é ȯÀÚ°¡ º¸´Ù È¿°úÀûÀ¸·Î È£ÈíÇÒ ¼ö ÀÖµµ·Ï ÇÏ°í ±â°èÀû ÀΰøÈ£Èí¿¡ ´ëÇÑ ÀÇÁ¸¼ºÀ» °¨¼Ò½ÃŰ´Â Áß¿äÇÑ ÇØ°áÃ¥À» Á¦°øÇÕ´Ï´Ù. SCI ȯÀÚ´Â Àå±âÀûÀΠȾ°Ý¸· Àڱؿ¡ ÀÇÇØ Å« ÇýÅÃÀ» ¹Þ°í È£Èí±â´É°ú Àü¹ÝÀûÀÎ »îÀÇ Áú ¸ðµÎ °³¼±µÇ±â ¶§¹®¿¡ ÀÌ ºÐ¾ß´Â °¡Àå Å« ¼ö¿ä¸¦ À̲ø°í ÀÖ½À´Ï´Ù. ±× °á°ú, SCI´Â ¿©ÀüÈ÷ Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·áÀÇ ÁÖ¿ä ÁßÁ¡ ºÐ¾ß°¡ µÇ¾ú½À´Ï´Ù.

Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå : Áö¿ªº° ºÐ¼®

Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á(DPT) ½Ã½ºÅÛ ½ÃÀåÀÇ ºÏ¹Ì´Â ±ÙÀ§Ã༺ Ãø»è °æÈ­Áõ(ALS), ô¼ö ¼Õ»ó, ÀΰøÈ£ÈíÀ» ÇÊ¿ä·Î Çϴ ȣÈí±â Áúȯ µî À¯º´·ü Áõ°¡¸¦ ÁÖÀÎÀ¸·Î ÇÏ´Â Å« ¼ö¿ä°¡ Ư¡ÀÔ´Ï´Ù. ¹Ì±¹Àº ÷´Ü ÀÇ·á ÀÎÇÁ¶ó, Çõ½ÅÀûÀÎ ÀÇ·á ±â¼ú äÅ÷üÀ» ³ôÀÌ°í °­·ÂÇÑ »óȯ Á¦µµÀÇ Æ²·Î ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù.

°Ô´Ù°¡, ±â°èÀû ÀΰøÈ£ÈíÀÇ ´ë¾ÈÀ¸·Î¼­ DPT¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ°í, ȯÀÚ Áß½ÉÀÇ ¼Ö·ç¼ÇÀÌ Á߽õǰí ÀÖ´Â °Íµµ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ij³ª´Ùµµ À¯¸ÁÇÑ ½ÃÀåÀÌÁö¸¸, ±× ±Ô¸ð´Â ¾ÆÁ÷ ÀÛ°í ÀÇ·á Áøº¸°¡ DPT ½Ã½ºÅÛÀÇ Ã¤¿ëÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ ÆÐ½º¿þÀÌ¿Í Á¤ºÎ ¹× ¹Î°£ ºÎ¹®ÀÇ ÀÌ´Ï¼ÅÆ¼ºê°¡ ÀÌ Áö¿ª Àüü ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª °í°¡ÀÇ Àåºñ ºñ¿ë, ÀϺΠÁö¿ª¿¡¼­ÀÇ Á¦ÇÑÀûÀÎ »óȯ, Àü¹®ÀûÀÎ ÀÇ·á ±³À°ÀÇ Çʿ伺°ú °ü·ÃµÈ °úÁ¦´Â ¿©ÀüÈ÷ º¸±Þ Àå¾Ö°¡ µÇ°í ÀÖ½À´Ï´Ù.

¹Ì±¹Àº ºÏ¹ÌÀÇ È¾°Ý¸· ÆäÀÌ½Ì Ä¡·á(DPT) ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ±¹°¡ÀÌÁö¸¸, ±× ÁÖµÈ ÀÌÀ¯´Â °í±Þ ÀÇ·á ÀÎÇÁ¶ó, ALS ¹× ô¼ö ¼Õ»ó°ú °°Àº Áúº´ÀÇ ³ôÀº À¯º´·ü, ÀÇ·á ±â¼ú Çõ½Å¿¡ ´ëÇÑ °­·ÂÇÑ Áö¿øÀÔ´Ï´Ù. ¹Ì±¹Àº »óȯ Á¦µµ°¡ È®¸³µÇ¾î Àֱ⠶§¹®¿¡ DPT ½Ã½ºÅÛ¿¡ÀÇ Æø³ÐÀº ¾×¼¼½º°¡ °¡´ÉÇÕ´Ï´Ù. ¶ÇÇÑ, ȯÀÚ Áß½ÉÀÇ ÀÇ·á ¹× ÃÖ÷´Ü ±â¼úÀÇ µµÀÔ¿¡ ÁßÁ¡À» µÐ °ÍÀº ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¾÷°èÀÇ ÁÖ¿ä ±â¾÷ÀÌ Á¸ÀçÇϰí Ⱦ°Ý¸· ÆäÀÌ½Ì ½Ã½ºÅÛÀÇ »õ·Î¿î ¿ëµµ¿¡ ´ëÇÑ Á¶»ç°¡ Áö¼ÓÀûÀ¸·Î ÀÌ·ç¾îÁö°í ÀÖ´Â °Íµµ ÀÌ ºÐ¾ß¿¡¼­ ¹Ì±¹ÀÇ ¿ìÀ§¼º¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå : °æÀï ±¸µµ

Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀåÀº °æÀïÀÌ Ä¡¿­Çϰí, ¿©·¯ ÁÖ¿ä ±â¾÷µéÀÌ ±â¼ú Çõ½Å, ±â¼úÀû Áøº¸, Àü·«Àû Á¦ÈÞ¸¦ ÅëÇØ ½ÃÀå Á¡À¯À²À» ´ÙÅõ°í ÀÖ½À´Ï´Ù. Synapse BiomedicalÀº ƯÈ÷ ÀÓ»ó ÇöÀå¿¡¼­ °¡Àå ³Î¸® »ç¿ëµÇ´Â NeuRx Diaphragm Pacing System¿¡¼­ ¾ÐµµÀûÀÎ ÈûÀ» º¸À̰í ÀÖ½À´Ï´Ù. Medtronic°ú Philips ÀÇÇÐÀº È£Èí ÄɾîÀÇ ¼¼°è Àü°³¿Í ±¤¹üÀ§ÇÑ Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ Ȱ¿ëÇÑ Áß¿äÇÑ °æÀï¾÷üÀÔ´Ï´Ù. Respiratory Technologies, Inc. ¹× Bioness, Inc.¿Í °°Àº ´Ù¸¥ ±â¾÷Àº ½Å°æ Áúȯ ¹× È£Èí±â ¹®Á¦°¡ Àִ ȯÀÚ¸¦ À§ÇÑ Æ¯¼ö ¼Ö·ç¼Ç¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ¶ÇÇÑ È¯ÀÚÀÇ °á°ú¸¦ °³¼±Çϰí ħ½ÀÀû Àΰø È£Èí¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ÁÙÀÌ´Â µ¥ ÁßÁ¡À» µÎ°í ÀÖÀ¸¸ç, ¿¬±¸ °³¹ß ÅõÀÚ Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù. °¢ ȸ»ç´Â Á¦Ç°ÀÇ À¯È¿¼º, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, »óȯ ¹üÀ§¿¡ µû¶ó °æÀïÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀÌ ¼ºÀåÇÔ¿¡ µû¶ó ÀÇ·á Á¦°ø¾÷ü¿ÍÀÇ Á¦ÈÞ¿Í ÆÇ¸Å ä³ÎÀÇ È®´ë°¡ °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇÑ Áß¿äÇÑ Àü·«ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå : »ê¾÷ ºÐ¼®

Á¦5Àå Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå »óȲ

Á¦7Àå Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦8Àå Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå : ¿ëµµº°

Á¦9Àå Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå : ±â¼úº°

Á¦10Àå Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦11Àå Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ½ÃÀå : Áö¿ªº°

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® : Ⱦ°Ý¸· ÆäÀÌ½Ì Ä¡·á ½Ã½ºÅÛ ¾÷°è

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Diaphragm Pacing Therapy System Market size was valued at US$ 5,567.23 Million in 2024, expanding at a CAGR of 7.5% from 2025 to 2032.

The Diaphragm Pacing Therapy System (DPTS) is a medical device designed to assist individuals with respiratory issues, particularly those with conditions such as spinal cord injuries, amyotrophic lateral sclerosis (ALS), or other diseases that impair diaphragm function. It works by electrically stimulating the diaphragm, allowing patients to breathe more effectively without relying solely on mechanical ventilation. The system typically consists of a pacemaker implanted near the diaphragm and electrodes that stimulate the muscle to contract, facilitating natural breathing. This therapy helps improve the quality of life for patients by enabling greater independence and reducing the need for invasive ventilatory support. The global Diaphragm Pacing Therapy System market is growing as awareness of the system's benefits spreads, driven by advances in technology and increased focus on improving the lives of individuals with respiratory disabilities. Demand is also rising due to the increasing prevalence of respiratory diseases and spinal cord injuries.

Diaphragm Pacing Therapy System Market- Market Dynamics

Technological innovations reduce device costs, expanding patient accessibility

Technological innovations in diaphragm pacing systems are crucial drivers for the market, as they contribute to reducing device costs and making these systems more accessible to a wider range of patients. Advances in miniaturization, battery life, and wireless connectivity are making DPT systems more affordable and user-friendly. These innovations also improve the overall efficiency and comfort of the device, making it a viable alternative to traditional mechanical ventilation. As a result, healthcare providers are more likely to adopt diaphragm pacing technology, especially for patients with chronic respiratory conditions.

Moreover, the development of more cost-effective manufacturing processes allows for broader market penetration, especially in underserved or lower-income regions. According to a report by the National Institutes of Health (NIH), technological advancements in medical devices, including diaphragm pacing, have led to a 15-20% decrease in device costs over the past decade, thereby increasing accessibility for a larger patient base. This is crucial in expanding the market for DPT systems, as affordability plays a significant role in adoption rates.

Diaphragm Pacing Therapy System Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.5% over the forecast period (2025-2032)

Based on Product Type segmentation, Implantable Diaphragm Pacing Systems (IDPS) was predicted to show maximum market share in the year 2024

Based on Application segmentation, Spinal Cord Injury (SCI) was the leading application in 2024

Based on Region, North America was the leading revenue generator in 2024

Diaphragm Pacing Therapy System Market- Segmentation Analysis:

The Global Diaphragm Pacing Therapy System Market is segmented based on Product Type, Application, Technology, End-User, and Region.

The market is divided into two categories based on product type: External Diaphragm Pacing Systems and Implantable Diaphragm Pacing Systems. In the Diaphragm Pacing Therapy System market, Implantable Diaphragm Pacing Systems (IDPS) dominate as the most significant segment. These systems offer long-term, reliable support for patients with respiratory insufficiency, particularly those with spinal cord injuries or neuromuscular disorders. Implantable systems are more discreet, efficient, and convenient compared to external systems, making them preferred for chronic use. Their ability to provide continuous, autonomous diaphragm stimulation enhances patient quality of life, driving their widespread adoption and market prominence. External Diaphragm Pacing Systems, while important, are typically used for short-term or less critical conditions.

The market is divided into four categories based on application: Spinal Cord Injury, Amyotrophic Lateral Sclerosis (ALS), Congenital Central Hypoventilation Syndrome (CCHS), and others. In the Diaphragm Pacing Therapy System market, Spinal Cord Injury (SCI) is the most prominent application segment. Patients with SCI, particularly those with high-level injuries, often suffer from respiratory failure due to diaphragm paralysis. Diaphragm pacing systems provide a critical solution, enabling these patients to breathe more effectively and reduce dependence on mechanical ventilation. This segment drives the largest demand, as SCI patients benefit significantly from long-term diaphragm stimulation, improving both respiratory function and overall quality of life. Consequently, SCI remains the key focus area for diaphragm pacing therapies.

Diaphragm Pacing Therapy System Market- Geographical Insights

The North American regional landscape for the Diaphragm Pacing Therapy (DPT) System market is characterized by significant demand, driven primarily by the increasing prevalence of conditions such as amyotrophic lateral sclerosis (ALS), spinal cord injuries, and respiratory diseases that necessitate ventilatory support. The U.S. holds the largest market share, due to its advanced healthcare infrastructure, higher adoption of innovative medical technologies, and strong reimbursement frameworks.

Further, rising awareness about DPT as an alternative to mechanical ventilation and the growing emphasis on patient-centric solutions contribute to market growth. Canada also presents a promising market, though it remains smaller in comparison, with ongoing healthcare advancements supporting the adoption of DPT systems. Regulatory approval pathways, along with initiatives from government and private sectors, are expected to further drive market expansion across the region. However, challenges related to high device costs, limited reimbursement in some areas and the need for specialized healthcare training remain obstacles to widespread adoption.

The United States is the leading country in the North American Diaphragm Pacing Therapy (DPT) System market, largely due to its advanced healthcare infrastructure, high prevalence of conditions like ALS and spinal cord injuries, and strong support for medical innovation. The U.S. benefits from a well-established reimbursement system, enabling broader access to DPT systems. Additionally, the country's focus on patient-centered care and cutting-edge technology adoption further drive market growth. Moreover, the presence of key industry players and ongoing research into new applications of diaphragm pacing systems contribute to the U.S.'s dominance in this space.

Diaphragm Pacing Therapy System Market- Competitive Landscape:

The Diaphragm Pacing Therapy System market is competitive, with several key players vying for market share through innovation, technological advancements, and strategic partnerships. Synapse Biomedical is a dominant player, particularly with its NeuRx Diaphragm Pacing System, which is the most widely used in clinical settings. Medtronic and Philips Healthcare are significant competitors, leveraging their global reach and extensive product portfolios in respiratory care. Other players like Respiratory Technologies, Inc. and Bioness, Inc. focus on specialized solutions for patients with neurological conditions and respiratory issues. The market is also characterized by a focus on improving patient outcomes and reducing the reliance on invasive ventilation, leading to increased investment in R&D. Companies are competing based on product effectiveness, regulatory approvals, and reimbursement coverage. As the market grows, partnerships with healthcare providers and expanded distribution channels are becoming key strategies for maintaining a competitive edge.

Recent Developments:

In January 2024, Lungpacer Medical announced the FDA's premarket approval for its AeroPace(TM) System. This device helps patients wean off mechanical ventilation by strengthening the diaphragm through phrenic nerve stimulation, improving recovery and reducing the risk of reintubation

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL DIAPHRAGM PACING THERAPY SYSTEM MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Diaphragm Pacing Therapy System Market Overview

2. Executive Summary

3. Diaphragm Pacing Therapy System Key Market Trends

4. Diaphragm Pacing Therapy System Industry Study

5. Diaphragm Pacing Therapy System Market: Impact of Escalating Geopolitical Tensions

6. Diaphragm Pacing Therapy System Market Landscape

7. Diaphragm Pacing Therapy System Market - By Product Type

8. Diaphragm Pacing Therapy System Market - By Application

9. Diaphragm Pacing Therapy System Market - By Technology

10. Diaphragm Pacing Therapy System Market - By End-User

11. Diaphragm Pacing Therapy System Market- By Geography

12. Key Vendor Analysis- Diaphragm Pacing Therapy System Industry

13. 360 Degree Analyst View

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â